Rethinking Research

Howie and Harlan discuss a concerning new COVID-19 variant, the discovery casting doubt on a major fish-oil study, and the need for new models of funding research. Links: “New Omicron subvariant Centaurus could be the most immune-evasive yet, expert warns” “Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia” “Effects of Randomized Treatment With Icosapent Ethyl and a Mineral Oil Comparator on Interleukin-1β, Interleukin-6, C-Reactive Protein, Oxidized Low-Density Lipoprotein Cholesterol, Homocysteine, Lipoprotein(a), and Lipoprotein-Associated Phospholipase A2: A REDUCE-IT Biomarker Substudy” Learn more about the MBA for Executives program at Yale SOM. Email Howie and Harlan comments or questions.